Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
0.0815
Dollar change
-0.0005
Percentage change
-0.61
%
IndexRUT P/E- EPS (ttm)-0.21 Insider Own38.95% Shs Outstand96.00M Perf Week-12.46%
Market Cap9.71M Forward P/E- EPS next Y- Insider Trans-31.74% Shs Float71.31M Perf Month-14.39%
Income-13.64M PEG- EPS next Q- Inst Own3.47% Short Float2.18% Perf Quarter-37.21%
Sales0.00M P/S- EPS this Y- Inst Trans-27.88% Short Ratio0.06 Perf Half Y-95.47%
Book/sh-0.09 P/B- EPS next Y- ROA-181.68% Short Interest1.55M Perf Year-98.80%
Cash/sh0.00 P/C64.74 EPS next 5Y- ROE-89.65% 52W Range0.08 - 7.83 Perf YTD-98.21%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-98.96% Beta2.21
Dividend TTM- Quick Ratio0.12 Sales past 5Y0.00% Gross Margin- 52W Low7.10% ATR (14)0.01
Dividend Ex-Date- Current Ratio0.12 EPS Y/Y TTM-524.01% Oper. Margin- RSI (14)38.44 Volatility14.37% 14.67%
Employees7 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-2290.32% Payout- Rel Volume0.46 Prev Close0.08
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume24.36M Price0.08
SMA20-13.60% SMA50-19.25% SMA200-93.66% Trades Volume11,218,949 Change-0.61%
Dec-12-24 07:30AM
Nov-21-24 07:30AM
Nov-19-24 04:30PM
Nov-05-24 07:40AM
Nov-04-24 07:30AM
04:45PM Loading…
Nov-01-24 04:45PM
Aug-28-24 08:00AM
Aug-12-24 07:00AM
Aug-08-24 06:30AM
Jul-16-24 02:52PM
08:12AM
07:43AM
07:30AM
Jun-13-24 08:00AM
May-29-24 04:21PM
09:53AM Loading…
May-15-24 09:53AM
Mar-19-24 10:57AM
07:00AM
Mar-11-24 02:26PM
07:00AM
Jan-31-24 08:30AM
Nov-02-23 08:30AM
Oct-30-23 08:39AM
Oct-11-23 08:30AM
Oct-06-23 09:29AM
08:30AM
Sep-22-23 09:01AM
Sep-20-23 05:40PM
Sep-13-23 08:30AM
Sep-07-23 04:30PM
04:05PM Loading…
Aug-31-23 04:05PM
Aug-16-23 08:30AM
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nirland Ltd10% OwnerOct 03 '24Sale0.101,500,000156,4508,400,000Oct 07 07:38 PM
Nirland Ltd10% OwnerOct 04 '24Sale0.101,368,991140,4587,031,009Oct 07 07:38 PM
Nirland Ltd10% OwnerOct 07 '24Sale0.10939,00996,5306,092,000Oct 07 07:38 PM
Nirland Ltd10% OwnerOct 01 '24Sale0.111,250,000141,37510,233,177Oct 02 05:02 PM
Nirland Ltd10% OwnerSep 30 '24Sale0.121,016,823122,01911,483,177Oct 02 05:02 PM
Nirland Ltd10% OwnerOct 02 '24Sale0.10333,17734,2519,900,000Oct 02 05:02 PM
Regan AndrewDirectorJul 16 '24Sale0.3210,244,3923,246,4481,691,727Sep 19 05:01 PM
Regan AndrewDirectorJul 17 '24Sale0.261,514,100391,092177,627Sep 19 05:01 PM
Regan AndrewDirectorJul 12 '24Sale0.251,389,820343,42512,941,319Sep 19 05:01 PM
Regan AndrewDirectorJul 11 '24Sale0.29882,952260,25314,331,139Sep 19 05:01 PM
Regan AndrewDirectorJul 15 '24Sale0.251,005,200248,38511,936,119Sep 19 05:01 PM
Regan AndrewDirectorJul 10 '24Sale0.33150,00050,07015,214,091Sep 19 05:01 PM
Regan AndrewDirectorJul 09 '24Sale0.4477,68133,85315,364,091Sep 19 05:01 PM
Regan AndrewDirectorJul 08 '24Sale0.5135,92318,32115,441,772Sep 19 05:01 PM
Regan AndrewDirectorJul 03 '24Sale0.641,00064015,477,695Sep 19 05:01 PM